Publications

Filters: Author is Kisseberth, W C  [Clear All Filters]
2007
Fosmire SP, Thomas R, Jubala CM, Wojcieszyn JW, Valli VEO, Getzy DM, Smith TL, Gardner LA, Ritt MG, Bell JS et al..  2007.  Inactivation of the p16 cyclin-dependent kinase inhibitor in high-grade canine non-Hodgkin's T-cell lymphoma.. Veterinary pathology. 44(4):467-78. Abstract
1996
London CA, Kisseberth WC, Galli SJ, Geissler EN, Helfand SC.  1996.  Expression of stem cell factor receptor (c-kit) by the malignant mast cells from spontaneous canine mast cell tumours.. Journal of comparative pathology. 115(4):399-414. Abstract
1995
Vail DM, MacEwen EG, Kurzman ID, Dubielzig RR, Helfand SC, Kisseberth WC, London CA, Obradovich JE, Madewell BR, Rodriguez CO.  1995.  Liposome-encapsulated muramyl tripeptide phosphatidylethanolamine adjuvant immunotherapy for splenic hemangiosarcoma in the dog: a randomized multi-institutional clinical trial.. Clinical cancer research : an official journal of the American Association for Cancer Research. 1(10):1165-70. Abstract
Kisseberth WC, MacEwen EG, Helfand SC, Vail DM, London CL, Keller E.  1995.  Response to liposome-encapsulated doxorubicin (TLC D-99) in a dog with myeloma.. Journal of veterinary internal medicine / American College of Veterinary Internal Medicine. 9(6):425-8.